Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Brain Dev ; 31(2): 169-72, 2009 Feb.
Article in English | MEDLINE | ID: mdl-18430534

ABSTRACT

Duchenne muscular dystrophy (DMD) is caused by mutation of the dystrophin gene. Cases of dystrophinopathy with a 2-bp deletion in the dystrophin gene commonly result in DMD. We report here a case of dystrophinopathy in a 9-years-old boy with a 2-bp deletion in exon 74 of the dystrophin gene; however, the boy had no clear clinical signs of muscle weakness. Immunohistochemical studies with N-terminal (DYS3) and rod-domain anti-dystrophin (DYS1) antibodies revealed that the dystrophin signals were weaker than in the control sample (non-dystrophinopathy) at the sarcolemma of myofibers, and the studies with C-terminus anti-dystrophin antibody (DYS2) were negative. Our patient's mutation is located between the binding sites of alpha-syntrophin and alpha-dystrobrevin. These results suggest that this mutation does not clearly induce muscle weakness at least through the age of 9 years.


Subject(s)
Dystrophin/genetics , Muscle Weakness/genetics , Sequence Deletion , Base Sequence , Binding Sites , Blotting, Western , Calcium-Binding Proteins/metabolism , Child , Dystrophin/metabolism , Dystrophin-Associated Proteins/metabolism , Exons , Genes , Humans , Immunohistochemistry , Male , Membrane Proteins/metabolism , Muscle Fibers, Skeletal/metabolism , Muscle Proteins/metabolism , Muscle Weakness/physiopathology , Sarcolemma/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...